Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (1491)

Name Institution Why
Peter D. Caravan, Ph.D.Massachusetts General Hospital Why?
Paul Edward Sax, M.D.Brigham and Women's Hospital Why?
Rebecca Zash, M.D.Beth Israel Deaconess Medical Center Why?
Mark Poznansky, Ph.D., M.B.,Ch.B.Massachusetts General Hospital Why?
Roger L. Shapiro, M.D.Harvard T.H. Chan School of Public Health Why?
Ralph Weissleder, Ph.D., M.D.Massachusetts General Hospital Why?
Rochelle P. Walensky, M.D.Massachusetts General Hospital Why?
Christopher T. Walsh, Ph.D.Harvard Medical School Why?
Kenneth Alan Freedberg, M.D.Harvard T.H. Chan School of Public Health Why?
Patrick Michael Reeves, Ph.D.Massachusetts General Hospital Why?
Matthew Steven Davids, M.D.Dana-Farber Cancer Institute Why?
Kenneth Carl Anderson, M.D.Dana-Farber Cancer Institute Why?
Byung Hee Yoo, Ph.D.Massachusetts General Hospital Why?
Jennifer Ruth Brown, Ph.D., M.D.Dana-Farber Cancer Institute Why?
Ahmed Elzoghby, Ph.D.Brigham and Women's Hospital Why?
Per Page    Page  of 100last Nextnext
Search Criteria
  • Heterocyclic Compounds
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.